In the last three years, the government has virtually shut down the disinvestment and privatisation programme.
JMP Securities adjusted their financial outlook on Ironwood Pharmaceuticals (NASDAQ:IRWD), setting a new price target of $14.00, a decrease from the previous target of $23.00. Despite the reduction, ...
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Ironwood Pharma (IRWD – Research Report), with a price ...
Tata Stael, Vodafone Idea, Indian Oil, Zomato, Bharat Electronics, SRF, JSW Energy, BHEL, IREDA, HAL, IndusInd Bank, Adani ...